{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:46:31Z","timestamp":1790142391703,"version":"4.0.1"},"reference-count":78,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Diabetes prevalence in older people residing in care homes is rising. This cohort of patients is characterised by multiple morbidities, polypharmacy, and frailty. As a result, they are exposed to an increasing burden of hypoglycaemia, which leads to unnecessary hospital visits and negative consequences. In addition, due to their high baseline morbidities, the risk of cardiovascular events increases. The newly introduced therapy of SGLT-2 inhibitors and GLP-1RA has a very low risk of hypoglycaemia and a significant cardiovascular protective effect. This makes it an appealing choice to be used in older people with complex morbidities, such as care home residents. So far, the current use of these agents is suboptimal in these settings because clinicians are cautious of side effects and tolerability, and also, clinical studies have not included this population. Furthermore, the guidelines in this area lack a personalised approach and are too general, with no clear specific description of which patients are suitable for such therapy. The currently available little evidence is indirect, which confirms the superior benefits of such therapy in frail compared with robust subjects, especially in those who are overweight or obese. The demographic mix of care homes is largely heterogeneous in terms of variations in body composition. In addition to malnourished, frail phenotype subjects, the prevalence of individuals with obesity living in these settings is increasing. Therefore, there is scope for increased use of these new agents in residents who have at least a normal or higher body weight. Because of the high baseline cardiovascular risk, these patients will benefit most from such therapy. Otherwise, these agents are better when less used for frail patients who are anorexic and malnourished because of the risk of inducing further weight loss, volume loss, low blood pressure, falls, and fractures.<\/jats:p>","DOI":"10.3390\/jpm16020062","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:48:04Z","timestamp":1769590084000},"page":"62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Demographic Mix of Care Homes and Personalised Use of SGLT-2 Inhibitors and GLP-1RAs in Residents with Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"16","author":[{"given":"Alan J.","family":"Sinclair","sequence":"first","affiliation":[{"name":"Foundation for Diabetes Research in Older People (fDROP), King\u2019s College, Droitwich Spa, London WR9 0QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza","family":"Waseem","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Rotherham General Hospital, Moorgate Road, Rotherham S60 2UD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Abdelhafiz","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Rotherham General Hospital, Moorgate Road, Rotherham S60 2UD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: An epidemiological analysis of linked primary care records","volume":"9","author":"Bennett","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: A systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/1475-6773.12607","article-title":"Stratifying patients with diabetes into clinically relevant groups by combination of chronic conditions to identify gaps in quality of care","volume":"53","author":"Magnan","year":"2018","journal-title":"Health Serv. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 13. Older Adults: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S266\u2013S282.","DOI":"10.2337\/dc25-S013"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/dc07-1425","article-title":"Diabetes in U.S. nursing homes, 2004","volume":"31","author":"Resnick","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1532-5415.2010.02786.x","article-title":"Trends in the Prevalence and Comorbidities of Diabetes Mellitus in Nursing Home Residents in the United States: 1995\u20132004","volume":"58","author":"Zhang","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.amjopharm.2011.05.001","article-title":"Prevalence of Diabetes and the Burden of Comorbid Conditions Among Elderly Nursing Home Residents","volume":"9","author":"Dybicz","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jamda.2013.08.001","article-title":"Prevalence, quality of care, and complications in long term care residents with diabetes: A multicenter observational study","volume":"14","author":"Newton","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_11","first-page":"10","article-title":"Antihyperglycemic Drug Use in Long-Stay Nursing Home Residents with Diabetes Mellitus","volume":"8","author":"Hume","year":"2022","journal-title":"J. Nurs. Home Res. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jgs.18649","article-title":"The prevalence and regional variability of diabetes among nursing home residents in Ontario","volume":"72","author":"Farahvash","year":"2024","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jamda.2014.11.009","article-title":"The characteristics of diabetic residents in European nursing homes: Results from the SHELTER study","volume":"16","author":"Brzyski","year":"2015","journal-title":"J. Am. Med Dir. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diacare.29.03.06.dc05-2205","article-title":"Diabetes in British nursing and residential homes: A pragmatic screening study","volume":"29","author":"Aspray","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40520-025-03008-5","article-title":"Prevalence and characteristics of older adults with type 2 diabetes mellitus living in French Caribbean nursing homes: Results from the baseline KASEHPAD study","volume":"37","author":"Simo","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diacare.24.6.1066","article-title":"Prevalence of Diabetes in Care Home Residents","volume":"24","author":"Sinclair","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1464-5491.2011.03261.x","article-title":"People living with diabetes resident in nursing homes--assessing levels of disability and nursing needs","volume":"28","author":"Gadsby","year":"2011","journal-title":"Diabet. Med."},{"key":"ref_18","first-page":"829","article-title":"Death rate of residents with diabetes in nursing homes","volume":"28","author":"Gadsby","year":"2011","journal-title":"Diabet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jamda.2005.04.009","article-title":"Comorbidities among Ohio\u2019s nursing home residents with diabetes","volume":"6","author":"Duffy","year":"2005","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jamda.2011.02.010","article-title":"Update on diabetes in the elderly and in nursing home residents","volume":"12","author":"Migdal","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1532-5415.2008.01904.x","article-title":"Care of patients with diabetes mellitus in long-term care facilities in Taiwan: Diagnosis, glycemic control, hypoglycemia, and functional status","volume":"56","author":"Chen","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12603-013-0351-x","article-title":"Hypoglycemic symptoms and hypoglycemia threshold in older people with diabetes\u2014A patient perspective","volume":"22","author":"Abdelhafiz","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Boulin, M., Diaby, V., and Tannenbaum, C. (2016). Preventing unnecessary costs of drug-induced hypoglycemia in older adults with type 2 diabetes in the United States and Canada. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162951"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(14)70176-7","article-title":"Diabetes in older people: New insights and remaining challenges","volume":"3","author":"Sinclair","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc15-2512","article-title":"Management of diabetes in long-term care and skilled nursing facilities: A position statement of the American diabetes association","volume":"39","author":"Munshi","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamainternmed.2014.136","article-title":"National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations","volume":"174","author":"Geller","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","article-title":"Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis","volume":"16","author":"Kojima","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Lapane, K.L., Tjia, J., Baek, J., Liu, S.H., and Ulbricht, C.M. (2021). Physical frailty and cognitive impairment in older nursing home residents: A latent class analysis. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02433-1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jamda.2017.12.101","article-title":"Frailty Screening (FRAIL-NH) and Mortality in French Nursing Homes: Results From the Incidence of Pneumonia and Related Consequences in Nursing Home Residents Study","volume":"19","author":"Theou","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liu, W., Puts, M., Jiang, F., Zhou, C., Tang, S., and Chen, S. (2020). Physical frailty and its associated factors among elderly nursing home residents in China. BMC Geriatr., 20.","DOI":"10.1186\/s12877-020-01695-5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"898.e1","DOI":"10.1016\/j.jamda.2017.06.016","article-title":"Heterogeneity of Different Tools for Detecting the Prevalence of Frailty in Nursing Homes: Feasibility and Meaning of Different Approaches","volume":"18","author":"Herce","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1717.e1","DOI":"10.1016\/j.jamda.2022.07.028","article-title":"Frailty in Nursing Homes-A Prospective Study Comparing the FRAIL-NH and the Clinical Frailty Scale","volume":"23","author":"Grosshauser","year":"2022","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jamda.2018.09.012","article-title":"Prevalence and Associated Factors of Sarcopenia in Nursing Home Residents: A Systematic Review and Meta-analysis","volume":"20","author":"Shen","year":"2019","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-019-1267-x","article-title":"Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis","volume":"24","author":"Papadopoulou","year":"2020","journal-title":"J. Nutr. Health Aging"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhu, Y., Tan, J.K., Ismail, A.H., Ibrahim, R., and Hassan, N.H. (2023). Factors Associated with Sarcopenia among Elderly Individuals Residing in Community and Nursing Home Settings: A Systematic Review with a Meta-Analysis. Nutrients, 15.","DOI":"10.3390\/nu15204335"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e12530","DOI":"10.1111\/opn.12530","article-title":"Obesity and its associated factors in older nursing home residents in three European countries-Secondary data analyses from the \u201cInternational Prevalence Measurement of Care Quality\u201d","volume":"18","author":"Schoberer","year":"2023","journal-title":"Int. J. Older People Nurs."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.1111\/cob.12697","article-title":"Obesity in European nursing homes participating in nutritionDay 2016\u20132021-Prevalence and resident characteristics","volume":"14","author":"Worf","year":"2024","journal-title":"Clin. Obes."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13821","DOI":"10.1002\/jcsm.13821","article-title":"Prevalence and Associated Factors of Sarcopenic Obesity Among Nursing Home Residents: A Cross-Sectional Multi-Centre Study","volume":"16","author":"Eglseer","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/gerona\/gly265","article-title":"The Increasing Prevalence of Obesity in Residents of U.S. Nursing Homes: 2005\u20132015","volume":"74","author":"Zhang","year":"2019","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_40","first-page":"54","article-title":"Anorexia of aging and its role for frailty","volume":"20","author":"Sanford","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_41","first-page":"1","article-title":"Assessment and management of appetite loss in older adults: An ICFSR task force report","volume":"12","author":"Cesari","year":"2023","journal-title":"J. Frailty Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ageing\/afaa014","article-title":"New horizons in appetite and the anorexia of ageing","volume":"49","author":"Cox","year":"2020","journal-title":"Age Ageing"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s40520-019-01292-6","article-title":"Differences in circulating appetite-related hormone concentrations between younger and older adults: A systematic review and meta-analysis","volume":"32","author":"Johnson","year":"2020","journal-title":"Aging Clin Exp. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2022.10.002","article-title":"Endocrinology of Taste with Aging","volume":"52","author":"Chia","year":"2023","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/appe.1993.1044","article-title":"Age-related changes in spontaneous food intake and hunger in humans","volume":"21","year":"1993","journal-title":"Appetite"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Calvani, R., Martone, A.M., Marzetti, E., Onder, G., Savera, G., Lorenzi, M., Serafini, E., Bernabei, R., and Landi, F. (2014). Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00269"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000512459","article-title":"Underweight in Nursing Homes: Differences between Men and Women","volume":"67","author":"Norman","year":"2021","journal-title":"Gerontology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.36150\/2499-6564-N497","article-title":"Food intake and prevalence of malnutrition in nursing homes. A multicenter observational study","volume":"70","author":"Castaldo","year":"2022","journal-title":"J. Gerontol. Geriatr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112005","DOI":"10.1016\/j.nut.2023.112005","article-title":"Too low protein and energy intake in nursing home residents","volume":"110","author":"Borkent","year":"2023","journal-title":"Nutrition"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Borkent, J.W., Van Hout, H.P.J., Feskens, E.J.M., Naumann, E., and de van der Schueren, M.A.E. (2023). Diseases, Health-Related Problems, and the Incidence of Malnutrition in Long-Term Care Facilities. Int. J. Env. Res. Public Health, 20.","DOI":"10.3390\/ijerph20043170"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ggi.14214","article-title":"Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus","volume":"21","author":"Abdelhafiz","year":"2021","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sinclair, A.J., and Abdelhafiz, A.H. (2023). Metabolic Impact of Frailty Changes Diabetes Trajectory. Metabolites, 13.","DOI":"10.3390\/metabo13020295"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sinclair, A., Siqueira, I., and Abdelhafiz, A. (2025). The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes. Metabolites, 15.","DOI":"10.20944\/preprints202505.0453.v1"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jamda.2023.03.020","article-title":"Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study","volume":"24","author":"Pandya","year":"2023","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1111\/jgs.18360","article-title":"Adoption of sodium glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents","volume":"71","author":"Hayes","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"107639","DOI":"10.1016\/j.jdiacomp.2020.107639","article-title":"Cardio-renal protection in older people with diabetes with frailty and medical comorbidities\u2014A focus on the new hypoglycaemic therapy","volume":"34","author":"Abdelhafiz","year":"2020","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.122.061754","article-title":"Efficacy and Safety of Dapagliflozin According to Frailty in Patients with Heart Failure: A Prespecified Analysis of the DELIVER Trial","volume":"146","author":"Butt","year":"2022","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/M21-4776","article-title":"Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: A post hoc analysis of the DAPA-HF trial","volume":"175","author":"Butt","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2337\/dc23-0671","article-title":"Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes","volume":"46","author":"Kutz","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2215\/CJN.0000000000000498","article-title":"EMPA-KIDNEY Collaborative Group. Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial","volume":"19","author":"Mayne","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"glad181","DOI":"10.1093\/gerona\/glad181","article-title":"Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty","volume":"79","author":"Vart","year":"2024","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"106396","DOI":"10.1016\/j.phrs.2022.106396","article-title":"SGLT2-inhibitors are effective and safe in the elderly: The SOLD study","volume":"183","author":"Lunati","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1111\/dom.15682","article-title":"Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes","volume":"26","author":"Riester","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jgs.17735","article-title":"Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes","volume":"70","author":"Lederle","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.jamda.2021.04.013","article-title":"Potential overtreatment and undertreatment of type 2 diabetes mellitus in long-term care facilities: A systematic review","volume":"22","author":"Stasinopoulos","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2016.0299","article-title":"Polypharmacy in the aging patient: A review of glycemic control in older adults with type 2 diabetes","volume":"315","author":"Lipska","year":"2016","journal-title":"JAMA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14283\/jfa.2017.39","article-title":"An international position statement on the management of frailty in diabetes mellitus: Summary of recommendations 2017","volume":"7","author":"Sinclair","year":"2018","journal-title":"J. Frailty Aging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s40520-023-02519-3","article-title":"Essential steps in primary care management of older people with Type 2 diabetes: An executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration","volume":"35","author":"Maggi","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_69","unstructured":"(2025, April 30). International Diabetes Federation Global Guidelines for Managing Older People with Type 2 Diabetes. Available online: https:\/\/ifa.ngo\/wp-content\/uploads\/2014\/02\/IDF-Guideline-for-Older-People.pdf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00163","DOI":"10.1002\/edm2.163","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review","volume":"3","author":"Lv","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s13410-020-00857-w","article-title":"The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus","volume":"40","author":"Zhang","year":"2020","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/gerona\/glw034","article-title":"Incidence of hip fracture in U.S. nursing homes","volume":"71","author":"Berry","year":"2016","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sohn, M., Nam, S., Nauck, M.A., and Lim, S. (2024). Long-term comparison of renal and metabolic outcomes after sodium\u2013glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC Med., 22.","DOI":"10.1186\/s12916-024-03483-z"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/dom.14108","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis","volume":"22","author":"Mantsiou","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"111662","DOI":"10.1016\/j.diabres.2024.111662","article-title":"Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review","volume":"211","author":"Parker","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Abdelhafiz, D., and Abdelhafiz, A. (2025). Practical Considerations in the Management of Frail Older People with Diabetes. Diseases, 13.","DOI":"10.3390\/diseases13080249"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/diabetology3020028","article-title":"Insulin in Frail, Older People with Type 2 Diabetes\u2014Low Threshold for Therapy","volume":"3","author":"Abdelhafiz","year":"2022","journal-title":"Diabetology"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Monti, G., Moreira, D.G., Richner, M., Mutsaers, H.A.M., Ferreira, N., and Jan, A. (2022). GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight. Cells, 11.","DOI":"10.3390\/cells11132023"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/2\/62\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:02:38Z","timestamp":1769590958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/2\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jpm16020062"],"URL":"https:\/\/doi.org\/10.3390\/jpm16020062","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}